Company · CIK 1844417
Estrella Immunopharma, Inc.
| CIK | 1844417 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Business address | CA |
| Listed | ESLA (Nasdaq), ESLAW (Nasdaq) |
| First annual or quarterly report | 2021-11-10 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292331 | 2025-12-22 | 2026-01-23 | 4 | |
| 333-283770 | 2024-12-12 | 2026-01-06 | 3 | |
| 333-274931 | 2023-10-11 | 2023-12-28 | 4 | |
| 333-253322 | 2021-02-19 | 2021-07-19 | 12 |
Filings
24| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-23 | EFFECTDeclared effective | 333-292331 | 9999999995-26-000279 |
| 2026-01-22 | S-1/AAmendment | 333-292331 | 0001213900-26-006410 |
| 2026-01-16 | S-1/AAmendment | 333-292331 | 0001213900-26-005233 |
| 2026-01-06 | 424B5Shelf takedown | 333-283770 | 0001213900-26-001686 |
| 2025-12-22 | S-1Registration filed | 333-292331 | 0001213900-25-124247 |
| 2024-12-19 | EFFECTDeclared effective | 333-283770 | 9999999995-24-003843 |
| 2024-12-12 | S-3Shelf registered | 333-283770 | 0001213900-24-108443 |
| 2023-12-28 | EFFECTDeclared effective | 333-274931 | 9999999995-23-003778 |
| 2023-12-18 | S-1/AAmendment | 333-274931 | 0001213900-23-096259 |
| 2023-11-13 | S-1/AAmendment | 333-274931 | 0001213900-23-086235 |
| 2023-10-11 | S-1Registration filed | 333-274931 | 0001013762-23-002940 |
| 2023-07-11 | EFFECTDeclared effective | 333-267918 | 9999999995-23-002052 |
| 2021-07-19 | 424B4Final prospectus | 333-253322 | 0001104659-21-093283 |
| 2021-07-14 | EFFECTDeclared effective | 333-253322 | 9999999995-21-002752 |
| 2021-07-09 | S-1/AAmendment | 333-253322 | 0001104659-21-090553 |
| 2021-07-01 | S-1/AAmendment | 333-253322 | 0001104659-21-088194 |
| 2021-06-11 | S-1/AAmendment | 333-253322 | 0001104659-21-080274 |
| 2021-05-28 | S-1/AAmendment | 333-253322 | 0001104659-21-074205 |
| 2021-05-25 | S-1/AAmendment | 333-253322 | 0001104659-21-071821 |
| 2021-05-18 | S-1/AAmendment | 333-253322 | 0001104659-21-068705 |
| 2021-05-07 | S-1/AAmendment | 333-253322 | 0001104659-21-062618 |
| 2021-04-12 | S-1/AAmendment | 333-253322 | 0001104659-21-048847 |
| 2021-03-29 | S-1/AAmendment | 333-253322 | 0001104659-21-042669 |
| 2021-02-19 | S-1Registration filed | 333-253322 | 0001104659-21-025854 |